zlacker

[parent] [thread] 5 comments
1. otikik+(OP)[view] [source] 2026-01-12 13:16:14
I think it’s not ozempic, it’s people not able to afford as much as before
replies(3): >>cbg0+C >>franci+w1 >>awakea+W4
2. cbg0+C[view] [source] 2026-01-12 13:18:10
>>otikik+(OP)
This study looks at households where someone is using something like Ozempic, not all households. It's the second paragraph of the story and the first sentence of the linked study.
replies(2): >>fph+c8 >>otikik+o8
3. franci+w1[view] [source] 2026-01-12 13:22:21
>>otikik+(OP)
Maybe? Although it sounds the study was able to differentiate between families where people were taking a GLP-1 vs families who were not.
4. awakea+W4[view] [source] 2026-01-12 13:40:01
>>otikik+(OP)
Read the article or just the headline?
◧◩
5. fph+c8[view] [source] [discussion] 2026-01-12 13:55:04
>>cbg0+C
True, but another factor is that the families where someone is taking a 300$-per-month medication have less money left to spend.
◧◩
6. otikik+o8[view] [source] [discussion] 2026-01-12 13:55:52
>>cbg0+C
It’s not cheap, especially in the US. That extra expense has to come from somewhere
[go to top]